Background Patients with metastatic breast cancer (MBC) are living longer, but the
development of brain metastases often limits their survival. We conducted a systematic …

This comprehensive review provides information on epidemiology, size, grade, cerebral
localization, clinical symptoms, treatments, and factors associated with longer survival in …

Previous evidence on postdiagnosis body fatness and mortality after breast cancer was
graded as limited‐suggestive. To evaluate the evidence on body mass index (BMI), waist …

Importance Evidence from the US National Cancer Institute Surveillance, Epidemiology, and
End Results (SEER) database suggests that the incidence of advanced breast cancer in …

Antibody-drug conjugates (ADCs) represent a novel class of molecules composed of a
recombinant monoclonal antibody targeted to a specific cell surface antigen, conjugated to a …

Contrary to the situation in early breast cancer, little is known about the prognostic relevance
of the hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) in …

The aim of the study was to assess the rate, pattern, and time of recurrence in patients with
triple-negative breast cancer (TNBC) and to evaluate factors influencing recurrence and …

Objectives To compare the diagnostic performance of [18F] FDG PET/MRI, MRI, CT, and
bone scintigraphy for the detection of bone metastases in the initial staging of primary breast …

Opinion statement Obesity not only is an independent risk factor of postmenopausal breast
cancer (BC), and in particular estrogen receptor-positive/progesterone receptor-positive BC …

Bone metastases are common in patients with advanced breast cancer. Given the significant
associated morbidity, the introduction of new, effective systemic therapies, and the …